Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ilse Hoffman"'
Autor:
Liselot De Vlieger, Lieselot Smolders, Lisa Nuyttens, Sophie Verelst, Christine Breynaert, Tim Vanuytsel, Ilse Hoffman, Dominique MA Bullens
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Pediatric eosinophilic esophagitis (ped-EoE) is an immune-mediated pathology affecting 34 per 100.000 children. It is characterized by an esophageal inflammation caused by an immune response towards food antigens that come into contact with the esoph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00fb7fc9dfd2fbab6554c854ad27f1c9
https://lirias.kuleuven.be/handle/123456789/676645
https://lirias.kuleuven.be/handle/123456789/676645
Autor:
Gert Van Assche, Ilse Hoffman, Ann Gils, Marc Ferrante, Severine Vermeire, Erwin Dreesen, Karen van Hoeve
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 68:847-853
Therapeutic drug monitoring has been proposed as a useful tool in the management of infliximab (IFX) treated patients with inflammatory bowel disease. The aim of this retrospective study was to determine whether IFX trough levels after induction ther
Autor:
Severine Vermeire, Ann Gils, Gert Van Assche, Erwin Dreesen, Ilse Hoffman, Marc Ferrante, Karen van Hoeve
Publikováno v:
Journal of Crohn's and Colitis. 12:1316-1325
Background The role of therapeutic drug monitoring for infliximab [IFX] therapy in children with inflammatory bowel disease [IBD] is poorly investigated. We determined if IFX exposure correlates with long-term remission in children. Methods In this r
Autor:
Ann Gils, Karen van Hoeve, Erwin Dreesen, Marc Ferrante, Ilse Hoffman, Severine Vermeire, Nasim Sadat Seyed Tabib, Sophie Tops
Publikováno v:
The Journal of Pediatrics. 240:150-157.e4
OBJECTIVES: To study infliximab (IFX) pharmacokinetics in children with inflammatory bowel disease (IBD) during induction therapy to predict outcome and explore if other covariates influenced outcome. STUDY DESIGN: All children with IBD starting IFX
Autor:
Pieter Vermeersch, Walter Fierz, Gert De Hertogh, Xavier Bossuyt, Laura Bogaert, Lieve Van Hoovels, Mathieu Cauchie, Ilse Hoffman
Publikováno v:
Autoimmunity reviews. 19(5)
BACKGROUND: The clinical presentation of celiac disease (CD) varies between children. The objective of this study was to document the pre-test probability for CD based on symptoms and routine laboratory test and to evaluate the performance of two IgA
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 64:918-924
Background Impaired gastric accommodation (GA) is proposed as a main pathophysiological mechanism for functional dyspepsia (FD). At present, the gastric barostat is the criterion standard to measure GA. Hence, this procedure is invasive and it may al
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 52(2)
Objectives In the era where new biologicals are entering the market, the place of immunomodulators in the treatment of pediatric inflammatory bowel disease (IBD) needs to be reassessed. Methods All children with Crohn’s disease (CD) or ulcerative c
Autor:
Ann Gils, Gert Van Assche, Severine Vermeire, Karen van Hoeve, Marc Ferrante, Erwin Dreesen, Ilse Hoffman
BACKGROUND: Rising evidence demonstrates that there are no differences in efficacy and safety between infliximab (IFX) originator and IFX biosimilar CT-P13 in the treatment of inflammatory bowel diseases (IBDs). However, most data are derived from ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46aa3f5c2556bae232617c5c3e6379e0
https://lirias.kuleuven.be/handle/123456789/634082
https://lirias.kuleuven.be/handle/123456789/634082
Autor:
Elisabeth De Greef, Denis Franchimont, Jean-Charles Coche, Stephanie Van Biervliet, Jean-François Rahier, Isabelle Paquot, Fernand Fontaine, Martine De Vos, W Arts, Gigi Veereman, Philippe Alliet, Patrick Bontems, Bruno Hauser, Françoise Smets, Filip Baert, Edouard Louis, Severine Vermeire, Peter Bossuyt, Olivier Dewit, Ilse Hoffman
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 63:253-258
Objective: The Belgian registry for paediatric Crohn disease (BELCRO) cohort is a prospective, multicentre registry for newly diagnosed paediatric patients with Crohn disease (CD) (
Autor:
Jean-François Rahier, V. Muls, Jérôme Paul, Stephanie Van Biervliet, Harald Peeters, Fernand Fontaine, Martine De Vos, Philippe Alliet, Filip Baert, Lucas Wauters, Françoise Smets, Patrick Bontems, Severine Vermeire, Geneviève Veereman, Jean-Charles Coche, Elisabeth De Greef, Tom G. Moreels, Isabelle Paquot, Peter Bossuyt, Olivier Dewit, Denis Franchimont, Edouard Louis, Els Van de Vijver, Ilse Hoffman, Bruno Hauser, W Arts
Publikováno v:
Inflammatory bowel diseases
Background: Accelerated step-up or anti-tumor necrosis factor (TNF) before first remission is currently not recommended in pediatric Crohn's disease. Methods: Five-year follow-up data from a prospective observational cohort of children diagnosed with